LifeArc appoints Dr Ian Campbell as Chief Business Officer
Published on 31 Jul 2020
AKL Research and Development partner with world-leading animal health company to test novel osteoarthritis drug in dogs
Published on 29 Jul 2020
TCR² Therapeutics Announces Recist Responses With First Tc-210 Dose Tested In Advanced Mesothelin-expressing Solid Tumors
Published on 27 Jul 2020
Press release: CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture
Published on 27 Jul 2020
Press Release: Over £100m cash boost to manufacture millions of doses of COVID-19 vaccine
Published on 23 Jul 2020
UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm
Published on 23 Jul 2020
Annual Review 2020 highlights impact on growth and productivity in the UK cell and gene therapy industry
Published on 20 Jul 2020
KQ Labs opens accelerator programme and announces LifeArc as a strategic partner
Published on 13 Jul 2020
LifeArc appoints Clare Terlouw to lead its life sciences investment strategy
Published on 13 Jul 2020

Peptinnovate announces change of name to Immune Regulation, strengthening of the Board and successful fundraise

Read the article
The appointment of these three experienced industry executives will bring valuable insight and resource to our Board and executive team. With their skills in immunology, clinical therapeutic development and strategy we have the expertise to advance our clinical programmes and look forward to the next stage of our progress.
Prof. Clive Page
Chairman of Immune Regulation
Freeline Closes $120 Million Series C Financing Round
Published on 2 Jul 2020
Achilles Therapeutics doses first patient in Phase I/II Study in advanced non-small cell lung cancer
Published on 24 Jun 2020
Achilles Therapeutics to set up manufacturing operations at the CGT Catapult manufacturing centre
Published on 8 Jun 2020
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
Published on 4 Jun 2020
LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus
Published on 29 May 2020
Achilles Therapeutics doses first patient in Phase I/II Study in recurrent or metastatic malignant melanoma with first TIL therapy to specifically target clonal neoantigens
Published on 29 May 2020
Cytiva launches VIA Capsule for the cryogenic shipment of cellular therapies
Published on 29 May 2020
Achilles Therapeutics announces formation of Scientific Advisory Board
Published on 15 May 2020
CiRA Foundation and the Cell and Gene Therapy Catapult set to launch new stem cell collaborative research
Published on 12 May 2020
Freeline receives Orphan Drug Designation from the FDA for FLT190 for the treatment of Fabry Disease
Published on 5 May 2020
Autifony Therapeutics announces commencement of a Phase I study of AUT00201, a novel Kv3 modulator for schizophrenia and hearing disorders
Published on 4 May 2020
MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology Primary tabs
Published on 23 Apr 2020

Copyright © 2020 Stevenage Bioscience Catalyst

Designed and built by Onespacemedia

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.